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Introduction and context {#s01}
========================

Integrins {#s01_01}
---------

Integrins are a large family of heterodimeric cell-surface receptors comprising one α and one β chain. To bind to ligands, integrins must first undergo a conformation change in a process known as activation \[[@bib-001]\]. In leukocytes, these conformational changes can be initiated by signaling downstream of other agonists such as chemokines \[[@bib-002]\]. Activated integrins cluster on the plasma membrane into small focal complexes or larger focal adhesions that are associated with the actin cytoskeleton \[[@bib-003],[@bib-004]\]. Integrin-based adhesion complexes can bind to either extracellular matrix proteins or proteins present on the surface of other cells. By directly connecting the cytoskeleton to surrounding matrix, integrin-mediated adhesions permit contractile forces to be directly applied to the adhesion to drive locomotion \[[@bib-005]\]. Integrin complexes are capable of adhering strongly to substrates; for example, the interaction between integrin α~L~β~2~ (lymphocyte function-associated antigen-1, or LFA-1) and intercellular adhesion molecule-1 (ICAM-1) on endothelial cells is strong enough for leukocytes to stick to endothelial cells in the presence of shear forces \[[@bib-006],[@bib-007]\]. The relationship between adhesion and cell motility is complex: many studies have shown that an intermediate amount of adhesion is optimal for cell migration; too much adhesion and cells cannot detach to move \[[@bib-008]\]. Conversely, if there is too little adhesion then cells cannot generate sufficient traction for locomotion \[[@bib-008]\].

The role of leukocyte motility in immune responses {#s01_02}
--------------------------------------------------

The recruitment of leukocytes from the circulation is critical for an effective immune response. First, leukocytes such as dendritic cells (DCs) need to move through peripheral tissues to 'scan' for signs of infection. After antigen uptake, they leave the tissue, enter lymphatic vessels, and travel large distances to reach lymph nodes \[[@bib-009]\]. Inside lymph nodes, cell motility continues in order for the antigen-presenting DC to find and activate the naïve T lymphocytes that recognise its unique major histocompatibility complex (MHC)-peptide complex. This process requires the scanning of thousands of lymphocytes, which are also migrating in search of the appropriate DC \[[@bib-010]\]. The activation of the lymphocyte promotes its sustained proliferation, and the expanding cohort of T lymphocytes leaves the lymph node and travels to the site of infection to eliminate the potential threat. The transit of these cells and other leukocytes to sites of inflammation is largely through the blood. Endothelial cells in inflamed tissues upregulate chemokines and adhesion molecules such as selectins in order to recruit leukocytes \[[@bib-011]\]. Selectins mediate intermediate-strength contacts with leukocytes that lead to leukocytes rolling along the endothelium \[[@bib-012]\]. Subsequently, integrins become activated, leading to the formation of firm adhesions that cause leukocyte arrest \[[@bib-012]\]. The critical role for integrins in this process is demonstrated by the immunodeficiency of patients with defective integrin α~L~β~2~ (LFA-1) and Kindlin-3 \[[@bib-013]\]. Thus, immune responses require cell motility to detect infection and for different cell types to meet and relay messages and, finally, to respond to the threat \[[@bib-014]\].

For an effective immune response, cell motility must be quick and efficient. Leukocytes move at speeds of greater than 10 μm/minute, which are an order of magnitude greater than the speed of cell types such as fibroblasts and epithelial cells \[[@bib-015]\]. These differing speeds of migration are also reflected in the differing organisation of integrin-mediated adhesions on two-dimensional (2D) substrates. Fibroblasts have large integrin-rich focal adhesions that turn over in a time frame of 10-30 minutes \[[@bib-003],[@bib-016]\]. The longevity of focal adhesions would be incompatible with the high migration speeds of leukocytes, and focal adhesions are not observed in leukocytes. Instead, very transient integrin complexes are present at the front of migrating leukocytes and a larger focal zone of integrins is observed in the middle of the cell \[[@bib-017]\]. Another challenge facing leukocytes is that they migrate through varying tissues containing different types of extracellular matrix. This problem could be overcome by using integrins that can bind to a broad range of ligands. Consistent with this notion, the leukocyte integrin beta 2 can bind to numerous different ligands, including plasma proteins (Factor X, C3bi, fibrinogen, and fibronectin) \[[@bib-018]\], extracellular matrix proteins (collagen and laminin) \[[@bib-019],[@bib-020]\], and other carbohydrate structures (including heparin-like glycosaminoglycans) \[[@bib-021]\]. Alternatively, adhesion molecules besides integrins could be used. So what exactly is the role of integrins in leukocyte migration?

Major recent advances {#s02}
=====================

Integrins are dispensable in certain contexts {#s02_01}
---------------------------------------------

The role of integrins in the interstitial migration of leukocytes was recently investigated by Lämmermann and colleagues \[[@bib-022]\], who genetically deleted all known integrin heterodimers and found that DCs were still able to migrate from tissue to lymph nodes unimpeded. Using two-photon microscopy, the authors confirmed that the motile behaviour of DCs in the skin and lymph nodes was indistinguishable from that of wild-type DCs \[[@bib-022]\]. Furthermore, entry of DCs into lymphatic vessels and movement through reconstituted three-dimensional (3D) matrices were unchanged in the absence of integrins \[[@bib-022]\]. These findings were not specific to DCs as integrins were dispensable for the movement of neutrophils and B cells in certain contexts. It has also been reported that T cells can move in the presence of integrin function-blocking antibodies \[[@bib-023]\]. However, extravasation of integrin-null DCs from the bloodstream to sites of inflammation was completely abolished, underlining the critical role for integrins in immune responses. The critical role of integrins in exit from the blood probably reflects the need for strong adhesions to counteract the shear stresses caused by blood flow. As expected, integrin depletion severely compromised the ability of leukocytes to adhere to ICAM-1 and fibronectin and move in 2D environments. On first inspection, these data suggest that the bi-phasic relationship of adhesion strength and motility may not apply in 3D contexts \[[@bib-024]\]. However, it is worth noting that the assays used to measure cell adhesion use planar 2D substrates that may not accurately reflect adhesion in 3D environments.

The mechanism described for this integrin-independent motility of DCs was critically dependent on actin polymerisation. ROCK (Rho kinase)- and myosin II-driven contraction of the actomyosin network was needed to couple the zone of actin polymerisation at the front of the cell to the nucleus and the rest of the cell body \[[@bib-022]\]. Forces applied by the actomyosin cytoskeleton could also deform the nucleus to allow squeezing through small spaces. This type of motility is similar to that of amoeboid cancer cells \[[@bib-025]\]. Further work from the same research group has shown a vital role of the small Rho GTPase Cdc42 in the coordination of protrusive activity required for efficient directional migration \[[@bib-026]\]. Undoubtedly, the mechanisms of leukocyte migration through the interstitium *in vivo* are just the beginning to be uncovered.

If integrins are dispensable for DC migration in some 3D environments, then how do the cells adhere to their surroundings? An important observation by Lämmermann and colleagues was that migration on a 2D plane requires integrins whereas migration between two 2D planes does not. Therefore, a confined environment is all that is needed to permit integrin-independent motility. An exact explanation for this phenomenon is not provided. One possibility is that, if a moving cell is confined around its lateral edges, it can push outwards and increase the friction provided by relatively weak non-integrin interactions between the cell surface and the confining substrates. The increased friction is then sufficient for traction. Conceptually, this is similar to the 'chimneying' technique used by climbers ([Figure 1](#fig-001){ref-type="fig"}). In the absence of confinement, the cell is unable to effectively push against its substrate. The lateral extension of protrusions into gaps in the matrix may also provide some traction \[[@bib-027]\].

![How weak adhesion might enable traction in confined spaces but not in open spaces\
**(a)** Strong adhesions enable actin polymerisation to drive the front of the cell forward (analogous to a man climbing a ladder). The main limitation is remodelling adhesions to enable the rear to follow. **(b)** If very weak adhesions are present, then there is insufficient friction and actin polymerisation cannot push the cell forward (analogous to a man trying to climb a smooth wall). **(c)** Friction generated from weak adhesions can be increased if the cells are pushed against substrate. This can happen in a confined environment (analogous to man climbing between two walls, or 'chimneying').](1757-594X-0001-0000000067-g001){#fig-001}

While the study of Lämmermann and colleagues demonstrates that integrins are not needed for motility in certain contexts, it does not demonstrate that wild-type cells move without using their integrins or provide alternative adhesion molecules. Insights into these issues were provided by Woolf and colleagues \[[@bib-028]\] in a study of T-cell migration within lymph nodes. The stromal cells of the lymph node such as fibroblastic reticular cells (FRCs) and the endothelium of the high endothelial venules (HEVs) can present both immobilised chemokines, such as chemokine (C-C motif) ligand-21 (CCL21), and integrin ligands such as VCAM-1 (vascular cell adhesion molecule-1) and ICAM-1. However, engagement of integrins within the lymph node could lead to excess adhesion and T-cell arrest before they encountered their specific antigen-presenting cell (APC), resulting in an impaired immune response. To dissect this issue, the roles of immobilised chemokines and integrin ligands were investigated*in vitro*. It was found that only immobilised chemokines were able to promote sustained T-cell motility and that this did not require additional adhesive signals such as integrin β1 engagement \[[@bib-028]\]. Immobilised CCL21 could induce clustering of integrin α~4~β~1~ (very late antigen-4, or VLA-4) and integrin α~L~β~2~ (LFA-1) on T cells; critically, however, although these integrins were clustered, they were not adhesive \[[@bib-028]\]. Furthermore, integrin-blocking antibodies could not prevent T lymphocytes moving within lymph nodes. Therefore, in these contexts, wild-type cells appear to move without using integrins, hence deletion of integrins does not affect motility within lymph nodes \[[@bib-022]\]. It is possible that the interaction between immobilised CCL21 and its binding partners on the cell surface, CCR7 \[chemokine (C-C motif) receptor-7\] and PSGL-1 (P-selectin glycoprotein ligand-1), could provide the adhesion necessary for cell migration, although this has not been demonstrated. Adhesion through integrins is induced only when the cells encounter shear forces in addition to chemokine signaling, such as T cells would encounter on the surface of HEVs when entering the lymph node from the circulation. The lack of integrin adhesiveness in the absence of shear flow has been termed 'integrin silencing' and provides an answer to the apparent contradiction of the presence of both integrin ligands and chemokines on FRCs where T cells need to be highly motile until they find their APC partner. Integrin silencing also occurs in neutrophils moving on fibrinogen in the absence of shear stress \[[@bib-028]\], suggesting that it may be a general mechanism in leukocytes. Integrin silencing can be over-ridden by strong signaling through the T-cell receptor \[[@bib-028]\]. Thus, once the T cell is presented with its cognate antigen, strong adhesions stop it from moving.

Future directions {#s03}
=================

Before these studies, it had been assumed that integrins were critical for leukocyte motility in all contexts. However, we now have a clearer framework of when integrins are used and when they are not. In situations in which cells need adhesions strong enough to halt motile behaviour and anchor cells in one place, integrins are critical. However, integrins are dispensable for movement through tissues at high speeds and to 'scan' large numbers of potential partners in a lymph node. Although integrins seem to be redundant in these contexts, it does not mean that migrating leukocytes do not require any form of adhesion. For actin polymerisation-driven changes in cell morphology to be successfully translated into locomotion, leukocytes may employ alternative adhesion molecules with lower affinities for their substrates. It is possible that chemokine-receptor interactions may fulfill this role but this is unproven as yet. These weaker adhesions would favour more transient interactions with matrix proteins and rapid cell motility. Integrins recruit a range of proteins to their cytoplasmic tails that couple to F-actin and these proteins enable the force generated by the actin cytoskeleton to act on the extracellular matrix. It remains to be determined how the actin cytoskeleton might connect to non-integrin adhesions used by rapidly migrating leukocytes. An effective immune response requires leukocytes to use both types of motility and to switch between them at the appropriate times. At present, our insights into the molecular details of how cells switch from integrin-dependent to -independent modes of motility are limited. No doubt, the next few years will yield answers to some of these issues and generate new, unexpected and exciting questions.
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